BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cyclodextrin Technologies Development, Inc. (CTDI) Release: NanoSonic Products, Inc. Ribbon-Cutting Event a Smashing Success


7/28/2011 8:52:51 AM

ALACHUA, FL--(Marketwire - July 28, 2011) -

NanoSonic Products, Inc., a CTD Holdings company (OTCQB: CTDH) (OTCBB: CTDH) (the "Company"), opened its new pulse drying facility Monday, July 25th, 2011 with a gala ribbon cutting ceremony. More than 140 people gathered to hear remarks from CTD Holdings, Inc. Chairman C.E. "Rick" Strattan, NanoSonic Products, Inc. President & CEO Dr. Jeffrey Tate, Alachua Mayor Gib Coerper, and Gainesville Area Chamber of Commerce President & CEO Brent Christensen. Following the program, Mayor Coerper cut the ribbon opening the facility for tours and Dr. Tate invited everyone to enjoy a Florida Style Bar-B-Que lunch. Reporters from the CBS and GTN television stations and the Gainesville Sun newspaper were on hand for interviews with the management and participants.

The NanoSonic Products, Inc. pulse drying facility, located across from Progress Corporate Park, home to University of Florida's Sid Martin Biotechnology Incubator, was open for guided tours from 11:30 AM to 1:30 PM on Monday, July 25, 2011.

"Now that the building renovation is complete, it was great to take a day for celebration and to show our many friends and colleagues what we have accomplished here," said Dr. Jeffrey Tate. "Once we complete a few inspections and finish the final equipment installation of our formulation and pulse dryer system we will be ready for our validation runs and full production."

The ribbon-cutting event provided an opportunity to use bricks and mortar to back up the company's words. The future investors who were able to see and touch NanoSonic Products' facilities and equipment walked away with a firm trust in the company's public information.

"The information the Company provides in its public statements can be taken to the bank, and so it should be; to wit, our previous announcement about the record second quarter sales," exclaimed CTD Holdings, Inc. Chairman & CEO C.E. "Rick" Strattan.

The Company's announced $369,348 record second quarter sales will be accompanied by a $25,157 net profit and $225,000 of working capital at the end of the quarter. The record sales figure is a result of a $145,000 sale to one of the company's largest customers.

"That sale was the result of persistence and customer service over the years. Be assured, now that we have landed this business, we are going to do our best to get it again!" stated Mr. Strattan.

About CTD Holdings, Inc.:
CTD Holdings, Inc. and its companies provide Trappsol® brand cyclodextrins and cyclodextrin derivatives, and Aquaplex® brand cyclodextrin complexes to researchers, R&D labs and industrial users in the medical, pharmaceutical, food, and nutritional industries. For more information regarding CTD Holdings, Inc., please visit: www.ctd-holdings.com.

Safe Harbor Statement:
This news release contains "forward-looking statements" about the Company's anticipated future operations. You are cautioned that such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include the Company's ability to obtain additional capital to expand operations as planned, demand for Company products and services, and availability of products and raw materials. The above forward-looking statements are made as of the date above; CTD Holdings, Inc. accepts no specific responsibility for updating such statements.


Contact:
David Corner
386-454-0887
investor@ctd-holdings.com

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->